AlphaGene Names Schechter as New President and CEO | GenomeWeb

WOBURN, Mass.--The bioinformatics company AlphaGene has named Alan Schechter as its new president and CEO, replacing George Scheele, who will remain as AlphaGene's chairman of the board and chief scientific officer.

Schechter was previously president and CEO of Applied Carotenoid Sciences Inc., a biopharmaceutical device R&D company. AlphaGene is focused on developing technologies for gene and protein discovery to accelerate drug development.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.